Outsourcing

Dec 01, 2015
BioPharm International
CMO industry consolidation may be frustrated by a dearth of attractive assets.
Dec 11, 2015
By BioPharm International Editors
Grand River Aseptic Manufacturing expands disposable technology capabilities at aseptic facility.
Dec 10, 2015
By BioPharm International Editors
Changes in China’s Food and Drug Administration (cFDA) drug development and commercialization policies make it easier for multinationals and CMOs to manufacture in China for in-country use, reports CMO and consultant PaizaBio.
Dec 07, 2015
While stakeholders generally welcome improvements to quality initiatives, they are concerned with how the new requirements will be implemented for more complicated supply-chain models.
Jul 01, 2015
BioPharm International Multimedia
By BioPharm International Editors
Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association speaks with BioPharm International.
Nov 23, 2015
By BioPharm International Editors
The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase I clinical trials.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 20, 2015
By BioPharm International Editors
Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.
Dec 01, 2015
BioPharm International
Use of a subspace model is a viable method to characterize process space variables and optimize process performance.
Nov 01, 2015
BioPharm International
Biopharma and contract providers must tread carefully amid changing market dynamics.
native1_300x100
lorem ipsum